EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. ABBV

Go back to EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments

EyePoint Pharmaceuticals (EYPT) Reports In-Line Q2 EPS

August 3, 2022 7:18 AM EDT

EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q2 EPS of ($0.52), in-line with the analyst estimate of ($0.52). Revenue for the quarter came in at $11.3 million versus the consensus estimate of $10.89 million.

For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.

... More